醒脑静注射液治疗重度颅脑损伤的疗效观察

目的观察醒脑静注射液治疗重度颅脑损伤的催醒疗效。方法将160例因颅脑损伤所致昏迷的患者（Glasgow评分3～8分）随机分为两组,均予常规治疗,包括依手术指征清除颅内血肿、去骨瓣减压术、脱水降颅内压治疗、抗感染及营养支持治疗等。治疗组（醒脑静注射液治疗组）80例患者在对照组（常规治疗组）基础上加用醒脑静注射液。根据Glasgow评分进行评价。结果治疗组Glasgow昏迷评分（GCS）升高较对照组有显著性差异（p〈0.05）。结论醒脑静注射液对治疗重型颅脑损伤后昏迷的催醒治疗疗效确切,是可靠的一种药物。

The clinical observation of XingNaojing injection in treatment of coma by craniocerebral injury

Objective To explore the clinical efficacy of XingNaojing injection on coma caused by craniocerebral injury.Methods 160 comatose patients caused by craniocerebral injury（Glasgow coma scale（GCS）,3 ～ 8] were randomly divided into two groups.All patients received routine therapy,including evacuation of intracranialhematoma,decompressive craniectomy according to operation indications,dehydration therapy to depress intracranial pressure,anti-infective therapy and supportive treatment,etal.The test group（n=80） were administrated the same treatment compared to the other 80 patiens in the control group besides receiving XingNaojing injection.And the clinical efficacy was evaluated by GCS.Results In test group,the GCS were increased significantly compared with those in control group（p 0.05）.Conclusion XingNaojing injection is aneffective choice on treatment of coma caused by craniocerebral injury.